Literature DB >> 28613921

High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.

Anna J Podolanczuk1, Elizabeth C Oelsner1, R Graham Barr1,2, Elana J Bernstein1, Eric A Hoffman3,4,5, Imaani J Easthausen1, Karen Hinckley Stukovsky6, Arindam RoyChoudhury7, Erin D Michos8, Ganesh Raghu9, Steven M Kawut10,11, David J Lederer1,2.   

Abstract

RATIONALE: Areas of increased lung attenuation visualized by computed tomography are associated with all-cause mortality in the general population. It is uncertain whether this association is attributable to interstitial lung disease (ILD).
OBJECTIVES: To determine whether high-attenuation areas are associated with the risk of ILD hospitalization and mortality in the general population.
METHODS: We performed a cohort study of 6,808 adults aged 45-84 years sampled from six communities in the United States. High-attenuation areas were defined as the percentage of imaged lung volume with attenuation values between -600 and -250 Hounsfield units. An adjudication panel determined ILD hospitalization and death.
MEASUREMENTS AND MAIN RESULTS: After adjudication, 52 participants had a diagnosis of ILD during 75,232 person-years (median, 12.2 yr) of follow-up. There were 48 hospitalizations attributable to ILD (crude rate, 6.4 per 10,000 person-years). Twenty participants died as a result of ILD (crude rate, 2.7 per 10,000 person-years). High-attenuation areas were associated with an increased rate of ILD hospitalization (adjusted hazard ratio, 2.6 per 1-SD increment in high-attenuation areas; 95% confidence interval, 1.9-3.5; P < 0.001), a finding that was stronger among men, African Americans, and Hispanics. High-attenuation areas were also associated with an increased rate of ILD-specific death (adjusted hazard ratio, 2.3; 95% confidence interval, 1.7-3.0; P < 0.001). Our findings were consistent among both smokers and nonsmokers.
CONCLUSIONS: Areas of increased lung attenuation are a novel risk factor for ILD hospitalization and mortality. Measurement of high-attenuation areas by screening and diagnostic computed tomography may be warranted in at-risk adults.

Entities:  

Keywords:  epidemiology; hospitalizations; mortality; pulmonary fibrosis; subclinical interstitial lung disease

Mesh:

Year:  2017        PMID: 28613921      PMCID: PMC5736977          DOI: 10.1164/rccm.201703-0555OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  27 in total

1.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

2.  Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

Authors:  Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2008-09       Impact factor: 10.247

3.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

4.  Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Elana J Bernstein; R Graham Barr; John H M Austin; Steven M Kawut; Ganesh Raghu; Jessica L Sell; Eric A Hoffman; John D Newell; Jubal R Watts; P Hrudaya Nath; Sushil K Sonavane; Joan M Bathon; Darcy S Majka; David J Lederer
Journal:  Thorax       Date:  2016-09-08       Impact factor: 9.139

5.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

6.  Identification of early interstitial lung disease in smokers from the COPDGene Study.

Authors:  George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu
Journal:  Acad Radiol       Date:  2009-09-24       Impact factor: 3.173

7.  Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers.

Authors:  Peter J Castaldi; Raúl San José Estépar; Carlos S Mendoza; Craig P Hersh; Nan Laird; James D Crapo; David A Lynch; Edwin K Silverman; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

8.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

9.  Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study.

Authors:  Elizabeth C Oelsner; J Jeffrey Carr; Paul L Enright; Eric A Hoffman; Aaron R Folsom; Steven M Kawut; Richard A Kronmal; David J Lederer; Joao A C Lima; Gina S Lovasi; Benjamin M Smith; Steven J Shea; R Graham Barr
Journal:  Thorax       Date:  2016-04-05       Impact factor: 9.139

10.  Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.

Authors:  Tetsuro Araki; Rachel K Putman; Hiroto Hatabu; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; David A Schwartz; Ivan O Rosas; George R Washko; George T O'Connor; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

View more
  32 in total

1.  Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Purnema Madahar; Daniel A Duprez; Anna J Podolanczuk; Elana J Bernstein; Steven M Kawut; Ganesh Raghu; R Graham Barr; Myron D Gross; David R Jacobs; David J Lederer
Journal:  Respir Med       Date:  2018-06-06       Impact factor: 3.415

2.  Looking at the Airway to Understand Interstitial Lung Disease.

Authors:  Justin M Oldham
Journal:  Ann Am Thorac Soc       Date:  2019-04

3.  Toward Early Identification of Clinically Relevant Interstitial Lung Disease.

Authors:  Margaret L Salisbury; David A Lynch
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

4.  Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.

Authors:  Rachel K Putman; Gunnar Gudmundsson; Gisli Thor Axelsson; Tomoyuki Hida; Osamu Honda; Tetsuro Araki; Masahiro Yanagawa; Mizuki Nishino; Ezra R Miller; Gudny Eiriksdottir; Elías F Gudmundsson; Noriyuki Tomiyama; Hiroshi Honda; Ivan O Rosas; George R Washko; Michael H Cho; David A Schwartz; Vilmundur Gudnason; Hiroto Hatabu; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

5.  Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.

Authors:  Margaret L Salisbury; Justin C Hewlett; Guixiao Ding; Cheryl R Markin; Katrina Douglas; Wendi Mason; Adam Guttentag; John A Phillips; Joy D Cogan; Sara Reiss; Daphne B Mitchell; Pingsheng Wu; Lisa R Young; Lisa H Lancaster; James E Loyd; Stephen M Humphries; David A Lynch; Jonathan A Kropski; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

6.  Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Authors:  Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

7.  Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.

Authors:  Gary M Hunninghake; Luisa D Quesada-Arias; Nikkola E Carmichael; Jose M Martinez Manzano; Sergio Poli De Frías; Maura Alvarez Baumgartner; Lisa DiGianni; Shannon N Gampala-Sagar; Dominick A Leone; Swati Gulati; Souheil El-Chemaly; Hilary J Goldberg; Rachel K Putman; Hiroto Hatabu; Benjamin A Raby; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

8.  Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.

Authors:  Justin M Oldham; Ayodeji Adegunsoye; Satinderpal Khera; Elyse Lafond; Imre Noth; Mary E Strek; Michael Kadoch; Jonathan H Chung
Journal:  Ann Am Thorac Soc       Date:  2018-06

9.  Reference values for high attenuation areas on chest CT in a healthy, never-smoker, multi-ethnic sample: The MESA study.

Authors:  Imaani Easthausen; Anna Podolanczuk; Eric Hoffman; Steven Kawut; Elizabeth Oelsner; John S Kim; Ganesh Raghu; Karen Hinckley Stukovsky; Susan Redline; Robyn L McClelland; R Graham Barr; David J Lederer
Journal:  Respirology       Date:  2020-02-17       Impact factor: 6.424

10.  Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Claire F McGroder; Carrie P Aaron; Suzette J Bielinski; Steven M Kawut; Russell P Tracy; Ganesh Raghu; R Graham Barr; David J Lederer; Anna J Podolanczuk
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.